Search results

  1. Murph

    Inhibition of IL-11 signalling extends mammalian healthspan and lifespan. (Widjaja, Cook, et al 2024)

    I should add that not only are the benefits visible in mice engineered to be low in IL-11 but also in mice given anti-IL-11 therapy once they were already old.
  2. Murph

    Inhibition of IL-11 signalling extends mammalian healthspan and lifespan. (Widjaja, Cook, et al 2024)

    Results here are pretty striking. Will be interesting to see how it pans out in humans if they try it for fibrotic lung disease. However the thing about ageing research in people is it takes a long time to collect data! Still I'm very excited about ageing research because it seems to...
  3. Murph

    Inhibition of IL-11 signalling extends mammalian healthspan and lifespan. (Widjaja, Cook, et al 2024)

    2024 Jul 17. doi: 10.1038/s41586-024-07701-9. Online ahead of print. Inhibition of IL-11 signalling extends mammalian healthspan and lifespan Anissa A Widjaja # 1 , Wei-Wen Lim # 2 3 , Sivakumar Viswanathan 2 , Sonia Chothani 2 , Ben Corden 3 4 , Cibi Mary Dasan 2 , Joyce Wei Ting...
  4. Murph

    Postacute Sequelae of SARS-CoV-2 Infection in the Pre-Delta, Delta, and Omicron Eras, 2024, Ziyad Al-Aly, M.D et al

    Surprised that the very first iteration of the virus caused more long covid than the delta-era one, which if i recall correctly, caused more severe acute illness. But overall this matches my prior which is that as the virus mutates to cause less serious illness, there's a lower rate of long...
  5. Murph

    Trial Report Blood Flow To The Head Is Reduced in a Patient With Myalgic Encephalomyelitis With Confirmed Post-Exertional Malaise, 2024, Lee

    The alternative to publishing an n=1 study isn't usually an n=10 study, it's putting it in the file drawer so nobody ever hears about it. I welcome all data of all kinds and all sample sizes. Nobody sets out to do half-finished, under-populated, under-powered studies but logistics can get in...
  6. Murph

    Financial Outcome Measure

    For someone like me, my earning power is very much linked to how well I feel. I have very short-term projects that I can complete on a day I feel well. If I'm in a good period I can make good money. At other times weeks go by with no earnings.So my health shows up in my bank account. But that...
  7. Murph

    Trial Report Cerebral blood flow and end-tidal CO2 predict lightheadedness during head-up tilt in patients with orthostatic intolerance, 2024, Novak

    Simple but massive breakthrough to have a measurable correlate of OI. If you can measure it you can manage it.
  8. Murph

    Cardiopulmonary and metabolic responses during a 2-day CPET in [ME/CFS]: translating reduced oxygen consumption [...], Keller et al, 2024

    So, this was an attempt to replicate two-day cpet with a really big sample and the differences persisted but don't look very big. Is that a fair summary? Is that why most of this thread is discussion of the inclusion criteria? People trying to explain why the differences don't look big? I...
  9. Murph

    USA: Mount Sinai PACS clinic and Dr David Putrino

    So you think there's sufficient empirical evidence to disprove the concept of viral latency / viral reservoirs in tissue? What about John Chia's work?
  10. Murph

    USA: Mount Sinai PACS clinic and Dr David Putrino

    I enjoyed the thread. There's definitely an emerging consensus among certain scientists in the US that there is a persistent pathogen (or pathogens). Do I think that's 100% likely to be true? No, the hit-and-run hypothesis is still plausible. Do I think it's a good clue worth digging into? 100%...
  11. Murph

    USA: Cornell Center for Enervating NeuroImmune Disease and Maureen Hanson

    she is certainly keen to distinguish them. Especialy to the exteent that long covid cohorts include people who were hospitalised and have organ damage; and that me/cfs is not caused by coronaviruses (and maybe, just maybe, all prior mecfs is from one virus.) and that mecfs patients have been...
  12. Murph

    AI-driven multi-omics modeling of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome, 2025, Xiong et al.

    This is a highly ambitious paper. Big sample and some very sophisticated statistical analysis. I like it. This study is worth combining with all our other metabolomic studies to see what is consistent and what is not. It seems to find a role for gut microbes, and their products, espeically...
  13. Murph

    Thesis Immune cell exhaustion, dysfunction, and metabolism in myalgic encephalomyelitis/chronic fatigue syndrome, 2023, Maya

    This thesis seems to be part of the evidence base for Hanson's swing to believing there's persistent infection. I observed a population of T cells that were positive for both CD4 and CD8 markers in both cohorts, as well as differences in the proportion of Tox+ cells within this population...
  14. Murph

    Preprint Circulating microclots are structurally associated with Neutrophil Extracellular Traps and their amounts are [up] in LC patients, 2024, Pretorius+

    For those of us who haven't heard of neutrophil extracellular traps before: The Expanding Role of Extracellular Traps in Inflammation and Autoimmunity: The New Players in Casting Dark Webs Stephanie U-Shane Huang and Kim Maree O’Sullivan* James L. Stafford, Academic Editor Author information...
  15. Murph

    Thesis Characterising the Electrophysiological Properties of Cells in Health and Disease [on ME/CFS], 2024, Clarke

    I just googled thesis embargos. They seem to imply something might be seeking publication or patenting. Which may be a hopeful sign.
  16. Murph

    Thesis Characterising the Electrophysiological Properties of Cells in Health and Disease [on ME/CFS], 2024, Clarke

    > 81.80% sensitivity and 85.70% specificity That's decent. Although not the stark difference Stanford found: Although the thesis talks about a 1.5 hour hyperosmotic challenge and the chart above shows the separation is not as strong at 1.5hour as it is a bit later.
  17. Murph

    Preprint Flow Clotometry: Measuring Amyloid Microclots in ME/CFS, Long COVID, and Healthy Samples with Imaging Flow Cytometry, 2024, Pretorius

    Strong paper. It provides further evidence for a fascinating observation in the disease; an observation that could suggest interventions. I'm pleased this avenue of enquiry is making progress.
  18. Murph

    Interventional Removal of Travelling Microthrombi Using Targeted Magnetic Microbubble, 2024, Li et al.

    Fascinating idea. Usually ideas out of China don't make much splash in the west but this paper is out of Tsinghua university which is China's #2 university, based in Beijing and their #1 tech/science university. Think MIT. So it is probably not junk science and could have some impact. The...
  19. Murph

    A causal link between autoantibodies and neurological symptoms in long COVID, 2024, Santos Guedes de Sa, Iwasaki et al

    I'm quite taken by this paper. I like the way they've not just hunted for auto-antibodies but tried to see what effects those autoantibodies might have on tissues and whole organisms. I don't think they're claiming definitive proof that AABs are the cause of long covid, but they do provide a...
  20. Murph

    Review Adolescence Onset Primary Coenzyme Q10 Deficiency With Rare CoQ8A Gene Mutation: A Case Report and Review of Literature, 2023, Hojabri et al

    Supplementing with good quality coq10 makes a notable positive difference to me. Could be worth trying a different brand!
Back
Top Bottom